Table 1.
Resected perihilar cholangiocarcinoma | |
---|---|
n = 231 | |
Age 1 | 65 (33–83) |
BMI 1 | 24.5 (16–41) |
Gender (male) 2 | 156 (60) |
ASA score 2 | |
1 | 12 (5) |
2 | 130 (56) |
3 | 85 (37) |
4 | 4 (2) |
Bismuth-Corlette 2 | |
I | 8 (4) |
II | 17 (7) |
IIIa | 55 (24) |
IIIb | 44 (19) |
IV | 100 (43) |
UICC stage 2 | |
I | 10 (4) |
II | 79 (34) |
IIIa | 31 (13) |
IIIb | 104 (45) |
IVa | 7 (3) |
IVb | 0 (0) |
Resection margin 2 | |
R0 | 154 (68) |
R1 | 73 (32) |
Lymph node status 2 | |
N0 | 122 (53) |
N+ | 109 (47) |
Microvascular invasion 2 | |
Yes | 41 (20) |
No | 160 (80) |
Histopathological grading 2 | |
Grade 1 | 11 (5) |
Grade 2 | 153 (67) |
Grade 3 | 63 (28) |
Perineural sheath infiltration 2 | |
Yes | 164 (90) |
No | 20 (11) |
Lymphangitis carcinomatosa 2 | |
Yes | 89 (46) |
No | 106 (54) |
T Stage 2 | |
1 | 16 (7) |
2a | 63 (27) |
2b | 67 (29) |
3 | 78 (34) |
4 | 7 (3) |
Resection side 2 | |
Left hepatectomy | 86 (37) |
Extended left hepatectomy | 15 (7) |
Left trisectionectomy | 71 (31) |
Right hepatectomy | 145 (63) |
Extended right hepatectomy | 6 (3) |
Right trisectionectomy | 139 (60) |
Surgical approach 2 | |
Standard major hepatectomy | 111 (48) |
Hilar en bloc resection | 120 (52) |
Portal vein resection 2 | |
Yes | 136 (59) |
No | 95 (41) |
Complications (Clavien-Dindo) 2 | |
None | 28 (12) |
I | 11 (5) |
II | 51 (22) |
IIIa | 62 (27) |
IIIb | 41 (18) |
IVa | 6 (3) |
IVb | 1 (0) |
V | 31 (12) |
CA 19-9 (kU/l) 1 | 63.0 (1–32670) |
ICU stay (days) 1 | 4 (2–123) |
Hospital stay (days) 1 | 23.0 (7–213) |
30-day mortality 2 | 16 (7%) |
90-day mortality 2 | 29 (13) |
Hospital readmission | 48 (21) |
Adjuvant chemotherapy | |
Yes | 39 (18) |
No | 182 (82) |
Recurrence / Death 2 | 176 (76) |
1 Data is presented as median and range. 2 Data is presented as count and proportions (%)